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Synthesis and cycloaddition reactions of strained
alkynes derived from 2,2’-dihydroxy-1,1’-biaryls†
Anish Mistry,a Richard C. Knighton, a Sam Forshaw, a Zakaria Dualeh,a
Jeremy S. Parker b and Martin Wills *a
A series of strained alkynes, based on the 2,2’-dihydroxy-1,1’-biaryl structure, were prepared in a short
sequence from readily-available starting materials. These compounds can be readily converted into
further derivatives including examples containing ﬂuorescent groups with potential for use as labelling
reagents. The alkynes are able to react in cycloadditions with a range of azides without the requirement
for a copper catalyst, in clean reactions with no observable side reactions.
Introduction
The use of highly reactive strained alkynes, typically within
eight-membered rings,1 in cycloaddition reactions with azides
is now a well-established reaction with numerous applications
in materials chemistry and in bioconjugation applications.2
Such reagents are ideal for these applications because the
cycloaddition reactions take place spontaneously and without
the need for a catalyst to be added – in contrast to the reac-
tions of unstrained terminal alkynes with azides in which case
a copper-based catalyst is generally required.3
Widely adopted cyclooctyne reagents such as 1–3 and their
derivatives (Fig. 1),4–6 are highly reactive, and can be used at the
low concentrations which are often required in bioconjugation
applications, particularly for in vivo reactions.7 In applications
where the concentration of reagents is more typical of synthetic
reactions e.g. 0.01–0.5 M, and on larger scales, less reactive
larger-ring molecules, which can be prepared through a short
synthetic sequence, have also proven to be synthetically valuable
reagents.8 Earlier and less reactive cyclooctynes remain syn-
thetically important, for example (2-cyclooctyn-1-yloxy)acetic
acid (a derivative of ‘OCT’) was the subject of a successful multi-
gram scale up optimisation study reported in 2018.5d Some
highly strained derivatives are also prone to addition of thiols.5e
In a recent paper, we reported the synthesis and appli-
cations of a class of strained alkyne based on the 10-mem-
bered structure 4, derived from 2,2′-dihydroxy-1,1′-biaryl com-
pounds.9 The unfunctionalised compound, 8,13-dioxatricyclo
[12.4.0.02,7]octadeca-1(14),2,4,6,15,17-hexaen-10-yne (dioxa-
biaryldecyne) 4 and its close derivatives are readily prepared in
one step through the reaction of 2,2′-biphenol with but-2-yne-
1,4-diyl bis(4-methylbenzene)sulfonate in the presence of pot-
assium carbonate.9 Before our studies, the reactions of alkynes
such as 4 with azides had not been reported, and just three
papers could be identified which reported the synthesis of the
same heterocyclic structure.10 In addition, we demonstrated
that reagents such as 4 and its derivatives react with azides,
without the need for a Cu catalyst, at rates similar to unfunc-
tionalised cyclooctyne, although lower than the most reactive
and recently reported strained alkynes. Significantly, although
longer reaction times are required than would be the case for
reagents such as 1–3, our alkynes reacted with azides in clean
reactions with no visible decomposition when followed by
1H-NMR. We also reported the synthesis of acid 5 and the acti-
vated ester 6 derivatives and demonstrated applicability to bio-
Fig. 1 Strained alkynes 1–3, dioxabiaryldecyne 4 and its derivatives 5
and 6.
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conjugation through its attachment to a number of peptides
and one protein in in vitro studies.9 Following our report,
another group reported the preparation of some of the same
derivatives, as well as N-containing heterocyclic variants,
together with a comprehensive molecular modelling study to
explain the enhanced reactivity of the reagents.11 This group
also demonstrated that the dioxabiaryldecynes do not rapidly
undergo reactions with thiols.11
In this paper we report the synthesis of a series of functio-
nalised analogues of the strained alkyne structure 4, in as little
as two steps, from readily available and inexpensive starting
materials, their subsequent functionalisation and representa-
tive applications to a number of cycloaddition reactions with
several azides.
Results and discussion
In order to develop an extended synthesis of dioxabiaryldecyne
reagents, we employed the reported coupling reactions of iodo-
benzaldehyde reagents 7 and 8 (iodovanillin) and 4-hydroxy-3′-
iodoacetophenone 9 with 2-(hydroxyphenyl)boronic acid 10,12
to give diols 11–13 respectively. This was followed by the
cyclisation reactions with ditosylate 14 using our previously-
reported procedure (Scheme 1).9 Strained alkynes 15, 16 and
17 were isolated respectively (Scheme 1). 3-Iodo-4-hydroxyben-
zaldehyde was prepared from 4-hydroxybenzaldehyde through
careful iodination using ICl/acetic acid.13 Iodovanillin can be
prepared by the same method but is readily commercially
available.
Both the Pd-catalysed coupling and the cyclisation to form
aldehydes 15 and 16 worked more eﬃciently for the product
containing a methoxy group adjacent to the strained alkyne,
giving a product in unoptimised but acceptable yield in each
case. In the case of the transformation of aldehyde 12 to 16,
we followed the reaction over time using chiral HPLC, which
resolved the two non-interconverting enantiomers of product
and allowed the conversion to be monitored over time (see
ESI† for HPLC details and graph of conversion over time). The
X-ray crystallographic structures of aldehyde 16 (Fig. 2) and
ketone 17 (Fig. 3) revealed the strained nature of the alkyne
within the constrained ring.
Alkyne 16 could also be reduced to the alcohol 19 using
sodium borohydride, which gave a clean product, however
attempts to reduce substrate 15, lacking the methoxy group, to
18 gave a complex mixture of products, for reasons that are not
clear.14
The strained alkynes prepared in this project are stable
solids at rt which can be stored for months without significant
decomposition. However a thermal gravimetric analysis (TGA)
was carried out in order to examine their stability at higher
temperatures. Aldehyde 16 exhibited a drop of ca. 10% mass
around 180 °C which may be associated with the loss of CvO
from the aldehyde, followed by a gradual mass loss of just over
20% as the temperature was raised to 600 °C. The TGA analysis
of the previously reported methyl ester of acid 5 was stable to
ca. 300 °C then gradually lost ca. 40% of its mass as the temp-
erature was increased to 600 °C (see ESI†).
Scheme 1 Synthesis of aldehyde-functionalised CBD strained alkynes
15–17 and alcohol 19.
Fig. 2 Single crystal X-ray crystallographic structure of 16 (two views;
ellipsoids are plotted at the 50% probability level). The bond angles at
the sp atoms are 165.2° and 165.3° and the biphenyl torsion angle is
72.2°.
Fig. 3 Single crystal X-ray crystallographic structure of 17 (two views:
ellipsoids are plotted at the 50% probability level). The bond angles at
the sp atoms are 165.1° and 168.6° and the biphenyl torsion angle is
66.4°.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2018
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
2 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
1/
19
/2
01
8 
9:
49
:1
8 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Given the improved synthesis of the methoxy-substituted
aldehyde 16 over 15, we focussed our studies on the former
reagent. Its reaction with a range of functionalised azides was
studied (Scheme 2) and in each case the reactions were fol-
lowed over time, using 1H NMR to monitor the cyclisations of
a 1 : 1 mixture of reagents in solution; the spectra are in the
ESI.† The reaction of 16 with benzylazide 20 was also carried
out in MeCN, the product 21 being isolated in 84% yield. In all
cases, the cycloadditions proceeded smoothly, with no obvious
accompanying decomposition of reagents. Conversions (by
NMR) and yields (isolated products) are given in Scheme 2. In
all cases the products were formed as inseparable regioiso-
meric mixtures in ca. 1 : 1–3 : 2 ratios. Benzylazide gave a clean
product 21 of addition, in analogy with previous reactions.9,11
An azide attached to a red dye, disperse red, 2215a gave a red
product 23 from the cycloaddition, which was carried out at
0.128 M, 9 days at rt (95% conversion, 76% isolated yield). An
azide containing a PEG-2000 chain, 24, also added cleanly to
the strained alkyne 16, and the product in this case (25) was
characterised by GPC as well as by NMR, revealing the
expected increase to the molar mass of the polymeric product
(ESI†). This was gratifying as the reagent concentration (0.025
M) in this example was lower than for other cycloadditions.
The cycloaddition of coumarin azide 26 gave a highly fluo-
rescent product 27 (see ESI†) as has been reported previously
for this class of reagent.15b,c For improved solubility, deuterated
acetonitrile was used as the solvent, and the reaction at 0.11 M
proceeded to ca. 80% conversion to 27. Although long reaction
times are required relative to the more reactive strained alkynes
such as 1–3, the benefits of the catalyst-free conditions and
clean cycloadditions make these reagents potentially valuable
for the preparation of materials for biological applications.
The addition of benzyl azide to alcohol 19 to give adduct 28
as a 3 : 2 regioisomeric mixture of products (Fig. 4) proceeded
at a similar rate (0.17 M, 5 d at rt, 97% yield, ESI†) indicating
that the functional group has minimal influence on the rate of
the cycloaddition, probably because of the separation from the
alkyne.
The aldehyde group on 15 and 16 permits their functionali-
sation with other reagents. The reaction of 15 with benzylhy-
droxylamine in MeOH overnight at 45 °C gave oxime ether 29
in 66% isolated yield. The formation of oxime ethers rep-
resents a valuable method for functionalisation due to their
high stability and ease of preparation.16 Also, notably, reduc-
tive amination with benzylamine led to the synthesis of amine-
containing derivatives 30 and 31. The reaction of methoxy-sub-
stituted 30 with benzylazide was found to proceed at a similar
rate to aldehyde-containing reagents 16 (ESI†). It was gratifying
that these functionalisations could be completed without
damaging the strained alkyne group.
The treatment of amine-functionalised polystyrene beads
with 16 and sodium cyanoborohydride was followed by reac-
tion of the functionalised beads 32 with disperse red azide 22.
After washing, the strong red colour of the dye remained on
the beads 33 (Scheme 3). As a control reaction, stirring the
solution of red dye-azide 22 with unfunctionalised beads gave
only lightly coloured beads after washing, indicating that the
cycloaddition had taken place on the dioxabiaryldecyne
reagent on the beads (ESI†).
Other reagents were prepared through reactions of the
aldehyde, notably fluorescent groups. The reductive amination
of 16 with the amine-functionalised dansyl reagent 34 resulted
in formation of 35 (Scheme 4A), which showed strong fluo-
rescent behaviour upon irradiation. A number of BoDIPY
derivatives 36–38 were also prepared through the direct reac-
tion of pyrroles with the aldehyde and BF3 in good yield
(Scheme 4B).17 Again, the ability to functionalise aldehyde 16
with a variety of reagents, without damaging the strained
alkyne, is noteworthy.
Fig. 4 Derivatives of 15–17.
Scheme 3 Functionalisation of beads with disperse red dye.
Scheme 2 Use of aldehyde alkyne 16 in addition reactions with a range
of azides.
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The X-ray crystallographic structure of 38 (Fig. 5) revealed
the strained nature of the alkyne but also that the BoDIPY
component was orientated almost perpendicular to the con-
nected arene ring, presumable with restricted rotation about
the connecting C–C bond. This accounts for the observed
diﬀerences in chemical shifts of the groups attached to the
heterocyclic rings of the BoDIPY unit in each of 36–38, which
will be in sharply diﬀerent diastereotopic environments.
The fluorescence spectra for compounds 35–38 are given in
the ESI.† However the strong and contrasting fluorescence
behaviour of the BoDIPY dyes 36–38 is sharply illustrated by
their response to UV irradiation. Compound 36 and 37 both
show strong fluorescence upon irradiation whereas 38 gives a
weaker response (ESI†).
The addition of benzylazide to BoDIPY derivative 36 was
tested and worked eﬃciently to give two regiosiomers 39 and
40 in a 1 : 1 ratio (Fig. 6). In this case, we were able to separate
the isomers by flash chromatography and independently
characterise them. We have not unambiguously established
which regiosiomer is which, of the two possibilities, however
on the basis of the positions of the methylene groups in the
13C-NMR spectra compared to previous examples, we have ten-
tatively assigned them as shown in Fig. 6 (see ESI†).
Further derivatives were also prepare from the corresponding
alcohol 19 using a variety of coupling methods (Fig. 7). These
included a biotin-containing reagent 41 which was formed
through formation of an ester bond to biotin in one step.
It was also possible to attach a group through a carbamate
i.e. 42, using N,N′-disuccinimidyl carbonate (DSC) as a coup-
ling agent to attach alcohol 19 to form the dansyl amine
derivative 34.7d,18 Finally, from the alcohol, the direct reaction
with an isocyanate could also be employed to create a derivative
Scheme 4 Synthesis of ﬂuorescent derivatives of 16.
Fig. 5 X-ray crystallographic structure of 38 (ellipsoids are plotted at the 50% probability level). The bond angles at the sp atoms are 165.7° and
168.1° and the biphenyl torsion angle is 68.6°.
Fig. 6 Separated cycloaddition products 39 and 40.
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with a carbamate linkage i.e. 43. Formation of derivatives from
the acid 5 was also investigated; the in situ formation of isocya-
nate from acid 5 using diphenylphosphoryl azide and trapping
with MeOH gave carbamate derivative 44 through a method that
could be used for future functionalisation. Acid 5 was also
linked using EDC·HCl to create the disperse-red functionalised
45. These results (Fig. 7) illustrate the range of methods which
can be employed to functionalise the strained alkynes.
In conclusion, we have prepared a selection of derivatives,
including fluorescently-labelled variants, of a new class of
strained alkyne, which benefit from ease of synthesis from
readily available and inexpensive starting materials through a
short sequence of reactions. We have demonstrated that this
class of alkyne undergoes uncatalysed cycloaddition reactions
with azides with minimal decomposition or side product for-
mation. Studies of the applications of these reagents are
ongoing and further results will be published in due course.
Experimental section
General experimental details, synthesis of intermediates 7,13 11,12
12,12 13,19 3420 and compounds 29–31 and 41–45 are in the ESI.†
Alkyne 15
A series of strained alkynes, based on the 2,2′-dihydroxy-1,1′-
biaryl structure, were prepared in a short sequence from
readily-available starting materials. This compound is novel.
2′,6-Dihydroxybiphenyl-3-carbaldehyde 11 (3.20 g,
14.9 mmol), potassium carbonate (10.22 g, 73.95 mmol) and
but-2-yne-1,2-diyl bis(4-methylbenzenesulfonate) 14 (5.31 g,
13.5 mmol) were added to a clean dry schlenk. The schlenk
was then put under nitrogen and purged, thereafter dry aceto-
nitrile (747 mL) was added to the mixture and the reaction left
to stir at rt for 10 days. The organics were removed under
vacuum, water (500 mL) and DCM (500 mL) were added and
the product extracted with DCM (3 × 300 mL). The organic
extracts were washed with brine and dried over Na2SO4, filtered
and concentrated under vacuum. The crude product was puri-
fied by column chromatography (8 : 2 hexane : ethyl acetate) to
aﬀord the product 15 as a white solid (1.50 g, 5.68 mmol,
38%). Mp 143–145 °C; (found (ESI-Q-TOF) [M + Na]+ 287.0675.
C17H12O3Na requires 287.0679); νmax 2910, 2863, 1686, 1568,
1495, 1473, 1415, 1345, 1305, 1288, 1188 cm−1; δH (500 MHz,
CDCl3) 9.98 (1H, s, CHO), 7.94 (1H, dd, J 8.4, 2.9, ArH), 7.75
(1H, d, J 2.0, ArH), 7.44–7.40 (1H, m, ArH), 7.32 (1H, d, J 8.3,
ArH), 7.22–7.19 (3H, m, ArH), 4.63–4.61 (1H, m, CH2),
4.54–4.50 (m, 1H, CH2), 4.41–4.32 (m, 2H, CH2); δC (125 MHz,
CDCl3) 191.2, 159.8, 154.4, 136.8, 134.9, 134.6, 132.6, 131.7,
129.7, 129.6, 124.3, 123.6, 122.6, 87.3, 86.0, 63.8, 63.5; m/z
(ESI) 287.1 ([M + Na]+).
Alkyne 16
This compound is novel.
2′,6-Dihydroxy-5-methoxybiphenyl-3-carbaldehyde 12 (1.70 g,
6.96 mmol), potassium carbonate (4.76 g, 34.4 mmol) and
but-2-yne-1,2-diyl bis(4-methylbenzenesulfonate) 14 (2.47 g,
6.27 mmol) were added to a schlenk. The schlenk was then
put under nitrogen and purged, thereafter dry acetonitrile
(346 mL) was added to the mixture and the reaction was left to
stir at rt for 10–14 days. The organics were removed under
vacuum, water (400 mL) and DCM (400 mL) were added and
the product extracted with DCM (3 × 200 mL). The organics
were collected and washed with brine and dried over Na2SO4,
filtered and concentrated under vacuum. The crude product
was purified by column chromatography (8 : 2 hexane : ethyl
acetate) to aﬀord 16 as a white solid (1.2 g, 4.08 mmol, 59%).
Mp 171–173 °C; (found (ESI-Q-TOF) [M + Na]+ 317.0787.
C18H14O4Na requires 317.0784); νmax 2951, 2923, 2852, 1687,
1601, 1580, 1491, 1459, 1426, 1384, 1334, 1290, 1240, 1180,
1163, 1127 cm−1; δH (500 MHz, CDCl3) 9.92 (1H, s, CHO), 7.49
(1H, s, ArH), 7.44–7.40 (1H, m, ArH), 7.33 (1H, s, ArH),
7.22–7.19 (3H, m, ArH), 4.69–4.66 (1H, m, CH2), 4.56–4.60 (2H,
m, CH2), 4.37–4.34 (1H, m, CH2) 3.98 (3H, s, OCH3); δC
(125 MHz, CDCl3) 191.5, 154.4, 154.2, 148.1, 137.6, 134.7,
132.7, 131.7, 129.7, 129.0, 124.4, 122.6, 108.6, 86.9, 86.7, 63.6,
60.5, 55.9; m/z (ESI) 317.1 ([M + Na]+). This reaction was also
monitored by HPLC over 14 days, using 15 : 85 IPA : Hexane,
Fig. 7 Functionalised derivatives of alcohol 19 and acid 5 strained
alkynes which were prepared in this project.
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1 ml min−1, IB column. Full details are in the ESI.† The X-ray
crystallographic structure of this compound was obtained and
is described in the ESI.†
Alkyne alcohol 19
This compound is novel.
NaBH4 (15 mg, 0.41 mmol, 1.0 eq.) was added carefully at
0 °C to a stirring solution of 16 (0.12 g, 0.41 mmol, 1.0 eq.) in
methanol (10 mL) under a nitrogen atmosphere and the reac-
tion was left for 1 hour to react at rt. The methanol was
removed under vacuum and the residue was redissolved in
ethyl acetate (15 mL). The organic extracts were washed with
sat. NH4Cl (15 mL) and then brine (15 mL). The organics col-
lected, dried over Na2SO4, filtered and concentrated under
vacuum to aﬀord a white solid. This was purified by column
chromatography (1 : 1 hexane : ethyl acetate) to aﬀord the
product 19 as a white solid (0.12 g, 0.40 mmol, 99%).
Mp 165–168 °C; (found (ESI-Q-TOF) [M + Na]+ 319.0940.
C18H16O4Na requires 319.0941); νmax 3522, 2927, 2866, 2835,
1587, 1494, 1446, 1421, 1338, 1264, 1246, 1192, 1165, 1133,
1122 cm−1; δH (400 MHz, CDCl3) 7.39–7.34 (1H, m, ArH),
7.19–7.17 (2H, m, ArH), 7.14 (1H, d, J 7.9, ArH), 7.01 (1H, d,
J 1.7, ArH), 6.74 (1H, d, J 1.8, ArH), 4.65 (2H, s, CH2OH),
4.63–4.57 (1H, m, CH2), 4.53–4.47 (1H, m, CH2), 4.41–4.36 (1H,
m, CH2), 4.34–4.28 (1H, m, CH2), 3.91 (3H, s, OCH3); δC
(100 MHz, CDCl3) 154.2, 153.3, 141.7, 137.0, 136.8, 135.8,
131.9, 129.1, 124.2, 122.4, 122.2, 109.9, 87.5, 85.9, 65.0, 63.5,
60.2, 55.7; m/z (ESI) 319.1 ([M + Na]+).
Ketoalkyne 17
This compound is novel.
In a round bottom flask under nitrogen atmosphere 13
(550 mg, 2.41 mmol, 1.2 equiv.) and but-2-yne-1,4-diyl-bis
(4-methylbenzenesulfonate) (792 mg, 2.01 mmol) were
dissolved in anhydrous acetonitrile (111 mL). K2CO3 (1.39 g,
10.0 mmol) was added and the mixture was stirred at RT for 14
days. The volatiles were removed in vacuum and H2O (50 mL)
was added. The product was extracted with DCM (3 × 50 mL).
The combined organic layers were washed with brine (30 mL),
dried over MgSO4, filtered and solvent removed via rotary
evaporation. The product was purified by column chromato-
graphy on silica (hexane/EtOAc = 4 : 1) to give 17 (252 mg,
0.906 mmol, 45%) as a crystalline white solid. Crystals suitable
for X-ray spectroscopy were grown by vapour diﬀusion of hexane
into a CHCl3 solution of the compound. Mp 137–139 °C.
(Found (ESI-Q-TOF) [M + Na]+ 301.0834. C18H14O3Na requires
301.0835); νmax 2158, 1679, 1499, 1357, 1307, 1251, 1188, 1106,
963 cm−1; δH (500 MHz, CDCl3); 8.00 (1H, d, J 8.4, ArH), 7.82
(1H s, ArH), 7.42–7.39 (1H, m, ArH), 7.25–7.18 (4H, m, ArH),
4.60–4.50 (2H, m, CH2), 4.39–4.32 (2H, m, CH2), 2.57 (3H, s,
CH3); δC (125 MHz, CDCl3) 197.3 (CvO), 158.7 (C), 154.2 (C),
136.1 (C), 135.0 (C), 133.5 (C), 132.9 (CH), 131.8 (CH), 129.1
(CH), 129.0 (CH), 124.8 (CH), 123.2 (CH), 123.0 (CH), 87.5 (C),
86.5 (C), 64.0 (CH2). 63.7 (CH2), 26.8 (CH3); m/z (ESI) 278.08
([M]+), 301.08 ([M + Na]+).
Cycloadduct 21
This compound is novel.
Alkyne 16 (30 mg, 0.102 mmol) and benzyl azide 20
(13.8 mg, 13 μL, 0.102 mmol) were stirred in MeCN (0.6 mL)
for 6 days at rt (ca. 0.17 M), monitoring each day by TLC. At
the end of this time the solvent was removed under vacuum
and the product purified by flash chromatography on silica gel
(hexane : EtOAc, 7 : 3) to yield the product 21 as a white solid
(40 mg, 0.94 mmol, 84%). TLC (hexane : EtOAc, 7 : 3), silica,
Rf 0.15; M.p. 181–184 °C; (found (ESI+): [M + Na]
+ 450.1426.
C25H21N3NaO4 requires 450.1424); νmax 1684, 1575, 1493, 1155,
722 cm−1; δH (500 MHz, CHCl3, two regioisomers 3 : 2); 9.94
(0.6H, s, CHO, major regiosomer). 9.91 (0.4H, s, CHO, minor
regiosomer), 7.52 (1H, s, ArH), 7.47–7.43 (2H, m, ArH),
7.35–7.30 (3H, m, ArH), 7.20–7.05 (2.6H, m, ArH, 3 × major
and 2 × minor regiosiomer), 7.01 (0.6H, t, J 7.0, ArH, major
regiosomer), 6.96 (0.4H, t, J 7.5, ArH, minor regiosomer), 6.90
(0.4H, t, J 7.5, ArH, minor regiosomer), 6.09 (0.4H, d, J 8.0, CH,
minor regiosomer), 5.87 (0.4H, d, J 11.0, CH, minor regio-
somer), 5.80–5.72 (1.2H, m, CH, 2 × major regiosomer), 5.57
(0.6H, d, J 13.0, CH, minor regiosomer), 5.52–5.45 (1.4H, m,
CH, 1 × major and 2 × minor regioisomer), 5.20 (0.6H, d,
J 15.0, CH, major regiosomer), 5.04 (0.4H, d, J 14.0, CH, minor
regiosomer), 4.96 (0.4H, d, J 11.0, CH, minor regiosomer), 4.83
(0.6H, d, J 13.0, CH, major regiosomer), 4.02 (3H, s, OCH3),
3.95 (3H, s, OCH3); δC (125 MHz, CDCl3) 191.0 (CH), 191.0
(CH), 153.8 (C), 153.6 (C), 152.7 (C), 152.6 (C), 151.7 (C), 145.0
(C), 144.2 (C), 134.9 (C), 134.1 (C), 133.6 (C), 133.1 (C), 133.0
(C), 132.6 (C), 132.4 (C), 131.4 (CH), 130.7 (CH), 129.5, (CH),
129.3 (CH), 129.0 (CH), 128.5 (C), 128.0 (C), 127.7 (CH), 127.1
(CH), 126.7 (CH), 122.3 (CH), 121.9 (CH), 113.2 (CH), 111.2
(CH), 110.6 (CH), 109.9 (CH), 67.5 (CH2), 62.6 (CH2), 61.0
(CH2), 57.7 (CH2), 56.2 (CH3), 56.1 (CH3), 53.0 (CH2), 52.0
(CH2). m/z (ES-API+) 450.0 ([M + Na]
+). The reaction was also
followed over time by 1H NMR and full details are in the ESI.†
Alkyne 16 (15 mg, 51.0 µmol) and benzyl azide 20 (6.4 mg,
51.0 µmol) were added together in deuterated chloroform
(0.4 mL) (0.128 M in both reagents) and the reaction was fol-
lowed at rt by 1H NMR.
Paper Organic & Biomolecular Chemistry
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Disperse red cycloadduct 23
This compound is novel.
Aldehyde 16 (15 mg, 51.0 µmol) and azide 22 (19 mg,
51.0 µmol) were combined in deuterated chloroform (0.4 mL)
and the reaction (ca. 0.128 M in both reagents) was left at rt.
The progression of the reaction was monitored daily. The pro-
gression of the reaction was monitored daily by 1H NMR
(ESI†). Upon completion, the reaction was worked up and the
product purified by column chromatography (DCM→85 : 15
DCM : EtOAc) to give 23 as a red solid (26 mg, 0.039 mmol,
76%). TLC DCM, silica, Rf 0.05; M.p. 155–158 °C; (found
(ESI+): [M + Na]+ 690.1843. C34H30ClN7NaO6 requires
690.1838); νmax 1688, 1597, 1513, 1333, 1121, 745 cm
−1; δH
(300 MHz, CHCl3) (two regioisomers 1 : 1); 9.95 (0.5H, s, CHO).
9.90 (0.5H, s, CHO), 8.50 (1H, s, ArH), 8.20–8.15 (1H, m, ArH),
8.05–8.00 (1H, m, ArH), 7.95–7.90 (1H, m, ArH), 7.80–7.75 (1H,
m, ArH), 7.45 (1H, d, J 13.0, ArH), 7.30–7.24 (3H, m, ArH),
7.15–7.05 (1H, m, ArH), 6.90–6.85 (1H, m, ArH), 6.80 (1H, d,
J 12.0, ArH), 6.75 (1H, d, J 12.0 ArH), 4.85 (1H, d, J 14.0, CH),
5.50–4.50 (5H, m, OCH and NCH), 4.10–3.80 (5H, m, NCH +
OMe), 3.35–3.00 (1H, m, NCH), 2.60–2.40 (1H, m, NCH), 1.15
(3H, t, J 6.5, CH3), 0.88 (3H, t, J 6.5, CH3); δC (125 MHz, CDCl3)
190.9, 190.8, 154.1, 153.8, 153.0, 152.8, 152.6, 152.5, 151.7,
151.3, 150.7, 150.5, 149.5, 147.3, 144.8, 144.7, 144.5, 134.3,
133.5, 133.0, 132.8, 132.8, 132.3, 131.5, 130.8, 129.1, 129.1,
129.0, 128.0, 127.0, 126.6, 126.0, 124.7, 122.6, 118.1, 116.0,
118.1, 113.1, 112.1, 111.4, 110.7, 109.9, 62.1, 60.8, 60.1, 58.6,
56.4, 50.4, 50.3, 46.0, 45.4, 11.8; m/z (ES-API+) 690.2
([M + Na]+).
PEG-2000 azide cycloadduct 23
This compound is novel.
PEG2000-azide 24 (25 mg, 12.5 µmol) and alkyne 16
(3.0 mg, 12.5 µmol) were added together in deuterated chloro-
form (0.5 mL) and the reaction left at r.t. (ca. 0.025 M in both
reagents). The progression of the reaction was monitored
daily. The final product was also analysed by GPC, ca. 14 days
for 100% conversion. The stacked spectra and the graph of
conversion/time, as well as GPC data, are in the ESI.†
Characteristic peaks of product were observed as follows: δH
(300 MHz, CDCl3) (ca. 1 : 1 ratio) 9.82 + 9.80 (1H, s × 2, CHO),
7.80–6.80 (6H, m, ArHs), 5.80–4.50 (6H, m, 2 × OCH2, NCH2
of addition product), 3.98 (3H, s, OCH3), 3.90 (3H, s, PEG
OCH3), 3.60–3.30 (ca. 190H, m, PEG OCH2 groups). Due to its
heterogeneous nature, only the 1H NMR and GPC data was
recorded for this complex, and the product was not purified
further.
Fluorescent coumarin dye cycloadduct 27
This compound is novel.
Compound 16 (13 mg, 44.2 µmol) and coumarin azide 26
(9.0 mg, 44.2 µmol) were added together in deuterated aceto-
nitrile (0.4 mL) and the reaction left at r.t. (ca. 0.11 M in
both reagents). The progression of the reaction was moni-
tored daily. Stacked NMR spectra and the conversion/time
graph are in the ESI.† At the end of this time (80% conver-
sion after 12 d) the solvent was removed and the product 27
was purified by column chromatography using a gradient of
EtOAc in hexane (14 mg, 28 µmol, 64%,). TLC hexane : EtOAc
3 : 7, silica, Rf 0.60; M.p. 222–228 °C; (found (ESI+):
[M + Na]+ 520.1119. C27H19N3NaO5 requires 520.1115); νmax
1725, 1688, 1605, 1574, 1223, 1133, 966, 684 cm−1;
δH (500 MHz, CHCl3) (two regioisomers ca. 3 : 2); 9.89 (1H, s,
CHO), 8.30–8.25 (0.4H, brs, NH or OH; by HSQC, minor
regioisomer), 8.12 (0.4H, s, CH, minor regioisomer),
8.10–8.05 (0.6H, brs, NH or OH; by HSQC, major regio-
isomer), 7.95 (0.6H, s, CH, major regioisomer), 7.50–7.45
(1H, m, ArH), 7.42 (0.6H, s, ArH, major regioisomer),
7.35–7.30 (1H, m, ArH), 7.25–7.15 (2H, m, ArH), 6.95–6.85
(2H, m, ArH), 6.82–6.80 (1.8H, m, ArH, 1 × major, 3 × minor
regioisomer), 6.65 (0.6H, d, J 10.0, ArH, major regioisomer),
5.88 (0.4H, d, J 13.0, OCH, minor regioisomer), 5.75 (0.6H,
d, J 13.0, OCH, major regioisomer), 5.52 (0.4H, d, J 12.0,
OCH, minor regioisomer), 5.35–5.25 (1H, m, OCH), 5.25
(0.6H, d, J 13.0, OCH, major regioisomer), 5.05–4.95 (1H, m,
0.4 OCH, minor regioisomer + 0.6 OCH, major regioisomer),
3.98 (1.2H, s, OCH3, minor regioisomer); 3.88 (1.8H, s,
OCH3, major regioisomer), 1.65 (1H, brs, OH); δC (125 MHz,
CDCl3), 191.3 (CH), 191.2 (CH), 162.6 (C), 162.3 (C), 157.7
(C), 157.5 (C), 155.9 (C), 153.8 (C), 152.7 (C), 152.5 (C), 151.4
(C), 147.5 (C), 142.5 (CH), 141.1 (CH), 136.0 (C). 134.9 (C),
132.7 (C), 132.5 (C), 131.6 (CH), 130.9 (CH), 130.8 (CH),
129.4 (C), 128.9 (C), 128.5 (CH), 128.1 (CH), 127.2 (C), 126.7
(C), 122.5 (CH), 122.1 (CH), 118.9 (C), 118.5 (C), 115.2 (CH),
114.9 (CH), 113.0 (CH), 111.1 (C), 111.0 (C), 110.9 (CH).
110.7 (CH), 110.1 (CH), 103.6 (CH), 103.5 (CH), 67.1 (CH2),
63.2 (CH2), 60.7 (CH2), 58.4 (CH2), 56.2 (CH3), 56.1 (CH3);
m/z (ES-API+) 520.0 ([M + Na]+).
Organic & Biomolecular Chemistry Paper
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Alcohol 19/benzyl azide Cycloadduct 28
This compound is novel.
Alcohol 19 (30 mg, 0.096 mmol) and benzyl azide 20
(13 mg, 12 μL, 0.096 mmol) were stirred in MeCN (0.6 mL) for
5 days, monitoring each day by TLC (0.16 M in each reagent).
At the end of this time the solvent was removed under vacuum
and the product purified by flash chromatography on silica gel
(hexane : EtOAc, 7 : 3) to yield the product 28 as a white solid
(40 mg, 0.093 mmol, 97%). TLC hexane : EtOAc, 7 : 3, silica,
Rf 0.1; M.p. 126–129 °C; (found (ESI+): [M + Na]
+ 452.1579.
C25H23N3NaO4 requires 452.1581); νmax 1589, 1492, 1444, 1423,
1335, 1273, 1161, 1138, 1108, 1004, 845, 798, 721 cm−1;
δH (500 MHz, CHCl3) (two regioisomers 3 : 2); 7.45–7.40 (1H,
m, ArH), 7.40–7.70 (10H, m, ArH), 5.95 (0.4H, d, J 8.0, CH,
minor regioisomer), 5.70–5.55 (2H, m, CH), 5.45–5.25 (2H, m,
CH), 5.05 (0.6H, d, J 14.0, CH, major regioisomer), 4.90 (0.4H,
d, J 16.0, CH, minor regioisomer). 4.70 (0.4H, d, J 12.0, CH,
minor regioisomer). 4.62 (0.6H, d, J 13.0, CH, major regio-
isomer), 4.58 (1.2H, brs, OCH2Ar, 2 × major regioisomer), 4.54
(0.8H, brs, OCH2Ar, 2 × minor regioisomer), 3.82 (1.4H, s,
OCH3, minor regioisomer), 3.80 (1.6H, s, OCH3, major regio-
isomer), 2.20 (1H, brs, OH). δC (125 MHz, CDCl3) 152.7 (C),
152.4 (C), 151.0 (C), 150.9 (C), 145.5 (C), 144.9 (C), 143.8 (C),
143.7 (C), 136.5 (C), 135.7 (C), 134.0 (C), 133.1 (C), 131.7 (C),
130.9 (C), 130.5 (C), 129.8 (CH), 128.5 (CH), 128.1 (C), 127.9
(C), 127.8 (CH), 127.7, (CH), 127.4 (CH), 127.3 (CH), 126.8
(CH), 126.2 (CH), 124.8 (CH), 123.5 (CH), 121.1 (CH), 112.0
(CH), 110.1 (CH), 110.0 (CH), 109.4 (CH), 66.2 (CH2), 64.0
(CH2), 63.9 (CH2), 61.4 (CH2), 59.8 (CH2), 56.5 (CH2), 55.0
(CH3), 54.8 (CH3), 51.9 (CH2), 50.9 (CH2).
m/z (ES-API+) 452.0 ([M + Na]+). The reaction was followed
over time in a separate run using alcohol 19 (15 mg,
0.050 mmol) and benzyl azide (6.5 mg, 0.050 mmol) in CDCl3
(0.4 mL) ([19] ca. 0.13 M). The conversion/time graph for a sep-
arate reaction is in the ESI.†
01Dansyl amine alkyne 35
This compound is novel.
N-(2-Aminoethyl)-5-(dimethylamino)naphthalene-1-sulfona-
mide 34 (100 mg, 0.34 mmol) was added to aldehyde strained
alkyne 16 (100.3 mg, 0.34 mmol) in THF (1 mL) and heated to
reflux for two hours. The reaction was cooled to ambient tem-
perature, NaBH4 (25.7 mg, 0.68 mmol) was added and stirred
for 18 hours. The reaction was diluted with EtOAc (5 mL),
washed with sat. aq. NaHCO3 (3 × 5 mL), and dried over
MgSO4. Purification by column chromatography (silica; EtOAc/
Hex; 20 : 80 → 50 : 50) aﬀorded 35 as a waxy green solid
(128 mg, 0.22 mmol, 66%). Mp 67–73 °C. (Found (ESI)
[M + H]+, 572.2212. C32H34N3O5S requires 572.2214). νmax
2923, 2784, 1587, 1489, 1234, 1102, 1003 and 757 cm−1;
δH (500 MHz, CDCl3) 8.52 (1H, d, J 8.5, ArH), 8.31–8.23 (2H, m,
ArH), 7.54–7.48 (1H, m, ArH), 7.45–7.37 (2H, m, ArH),
7.22–7.15 (3H, m, ArH), 7.08 (1H, d, J 7.5, ArH), 6.79 (1H, d,
J 2.0, ArH), 6.53 (1H, d, J 1.9, ArH), 4.62–4.49 (2H, m, OCH2),
4.43–4.27 (2H, m, OCH2), 3.90 (3H, s, OCH3), 3.45 (2H, d, J 5.3,
NCH2), 2.95 (2H, t, J 5.6, NCH2), 2.85 (6H, s, N(CH3)2).
δC (126 MHz, CDCl3) 154.5, 153.3, 152.1, 141.5, 136.9, 136.1,
135.9, 134.7, 132.1, 130.5, 130.0, 129.9, 129.7, 129.3, 128.6,
124.4, 123.3, 123.3, 122.7, 118.8, 115.3, 110.9, 87.7, 86.2, 63.7,
60.4, 55.9, 53.0, 47.3, 45.5, 42.6. m/z (ESI) 570 ([M + H]+, 100%)
and 606 ([M + Na]+, 10%); UV-Vis (MeCN) λmax (ε/M
−1 cm−1):
338 (10 500), 234 ((36 200) nm; fluorescence (MeCN; λex =
367 nm); λem 510 nm.
2,4-Dimethyl-3-ethyl BoDIPY strained alkyne 36
This compound is novel.
To a solution of alkyne 16 (100 mg, 0.340 mmol, 1.0 eq.) in
DCM (22 mL) was added 3-ethyl-2,4-dimethylpyrrole (87.3 mg,
0.1 mL, 0.71 mmol, 2.1 eq.), at which point the solution
became red, TFA (3.9 mg, 2 µL, 34 µmol, 0.1 eq.) was added,
resulting in the formation of a green solution which was
stirred for 3 h, during which time it returned to a red colour.
The solution was then washed with a saturated solution of
NaHCO3 (20 mL), turning the organic layer yellow, and brine
(20 mL). The organic layer was then dried over MgSO4, which
was subsequently removed by filtration, and the solvent was
evaporated. The residue was then dissolved in toluene
(12.3 mL) and a suspension of DDQ (84 mg, 0.37 mmol,
1.1 eq.) in toluene (6 mL) was added, resulting in the solution
turning purple. The mixture was then stirred for 1 h before
TEA (141 mg, 0.20 mL, 1.4 mmol, 4.1 eq.) was added along
with BF3·Et2O (290 mg, 0.25 ml, 2.04 mmol, 6.0 eq.) and the
mixture was refluxed at 75 °C for 45 min. The mixture was
then cooled before being filtered through a silica plug eluted
with DCM. The resultant solution was then concentrated
under vacuum to aﬀord the crude product. The product was
purified by column chromatography using an eluent of 2 : 8
EtOAc : pet. ether to aﬀord the pure product 36 as a red/green
metallic solid (128 mg, 0.225 mmol, 66%). (Found (ESI)
[M + Na]+ 591.2609 C34H35BF2N2NaO3 requires 591.2601;
vmax 2962, 2928, 2868, 1536, 1454, 1315, 1182, 972 and
960 cm−1; δH (500 MHz, CDCl3) 7.38 (1H, t, J 7.5, ArH),
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2018
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
2 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
1/
19
/2
01
8 
9:
49
:1
8 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
7.17–7.22 (1H, m, ArH), 7.14 (1H, d, J 7.9, ArH), 6.87 (1H, d,
J 1.5, ArH), 6.78 (1H, d, J 1.7, ArH), 4.62–4.71 (1H, m, CHH),
4.46 (2H, d, J 13.9, 2 × CHH), 4.31–4.39 (1H, m, CHH), 3.89
(3H, s, OCH3), 2.54 (3H, s, CH3), 2.51 (3H, s, CH3), 2.35 (2H, q,
J 7.5, CH2CH3), 2.29 (2H, q, J 7.6, CH2CH3), 1.64 (3H, s, CH3),
1.45 (3H, s, CH3), 1.03 (3H, t, J 7.6, CH2CH3), 0.97 (3H, t,
J 7.5, CH2CH3); δC (125 MHz, CDCl3) 154.4, 154.1, 153.8, 153.7,
142.7, 139.5, 138.7, 138.2, 138.0, 135.3, 132.7, 131.7, 131.6,
130.8, 130.7, 129.4, 124.3, 124.1, 122.6, 111.2, 87.2, 86.1, 63.3,
60.5, 56.1, 17.2, 17.1, 14.7, 14.6, 12.5, 11.8 and 11.4;
δF (376 MHz, CDCl3) −146.53–−145.15 (brm); m/z (ESI) 591
([M + Na]+). Fluorescence (MeCN; λex = 524 nm); λem = 534 nm;
UV-Vis (MeCN) λmax (ε/M
−1 cm−1): 520 (14 700) nm.
2,4-Dimethyl BoDIPY Strained alkyne 37
This compound is novel.
To a solution of aldehyde 16 (100 mg, 0.340 mmol, 1.0 eq.)
in DCM (22 mL), 2,4-dimethylpyrrole (67 mg, 0.71 mmol,
2.1 eq.), TFA (3.8 mg, 34 µmol, 0.1 eq.) was added and the
solution was stirred for 3 h. The solution was then washed
with a saturated solution of NaHCO3 (20 mL) and brine
(20 mL). The organic layer was then dried over MgSO4, which
was subsequently removed by filtration, and the solvent evap-
orated. The residue was then dissolved in toluene (12.3 mL)
and a suspension of DDQ (84 mg, 0.37 mmol, 1.1 eq.) in
toluene (6 mL) was added. The mixture was then stirred for 1 h
before TEA (141 mg, 1.4 mmol, 4.1 eq.) was added along with
BF3·Et2O (290 mg, 2.04 mmol, 6.0 eq.) and the mixture was
refluxed at 80 °C for 45 min. The mixture was then cooled to
rt, before being filtered through a silica plug eluted with DCM.
The resulting solution was then concentrated under vacuum to
aﬀord the crude product. The crude product was purified by
flash column chromatography to aﬀord the pure product 37 as
an orange/green metallic solid (38 mg, 0.074 mmol, 22%). Rf =
0.44 (Hexane–EtOAc 3 : 1); (found (ESI)) [M + Na]+ 535.1983.
C30H27BF2N2NaO3 requires 535.1980; vmax 2955, 2922, 2853,
1536, 1504, 1456, 1264 and 964 cm−1; δH (500 MHz, CDCl3)
7.35–7.41 (1H, m, ArH), 7.23–7.25 (1H, m, ArH), 7.17–7.22 (1H,
m, ArH), 7.11–7.16 (1H, m, ArH), 6.86 (1H, s, ArH), 6.77 (1H, s,
ArH), 6.03 (1H, s, MeCCHCMe), 5.97 (1H, s, MeCCHCMe), 4.66
(1H, d, J 15.4, CHH), 4.40–4.48 (2H, m, 2 × CHH), 4.33 (1H, d,
J 15.4, CHH), 3.88 (3H, s, OCH3), 2.56 (3H, s, CH3), 2.53 (3H, s,
CH3); δC (125 MHz, CDCl3) 155.5, 155.4, 154.4, 154.2, 143.5,
142.9, 141.0, 138.2, 135.2, 131.5, 131.3, 130.7, 129.4, 124.3,
123.8, 122.6, 121.2, 121.1, 110.8, 87.2, 86.1, 63.2, 60.5, 56.1,
14.5 and 14.1; m/z (ESI) 535 ([M + Na]+); fluorescence (MeCN;
λex = 504 nm); λem = 510 nm; UV-Vis (MeCN) λmax (ε/M
−1 cm−1):
498 (18 407) nm.
BoDIPY strained alkyne 38
This compound is novel.
To a solution of aldehyde 16 (100 mg, 0.340 mmol, 1.0 eq.)
in DCM (22 mL) pyrrole (47 mg, 0.71 mmol, 2.1 eq.), TFA
(3.8 mg, 34 µmol, 0.1 eq.) was added and the solution was
stirred for 3 h. The solution was then washed with a saturated
solution of NaHCO3 (20 mL) and brine (20 mL). The organic
layer was then dried over MgSO4, which was subsequently
removed by filtration, and the solvent evaporated. The residue
was then dissolved in toluene (12.3 mL) and a suspension of
DDQ (84 mg, 0.37 mmol, 1.1 eq.) in toluene (6 mL) was added.
The mixture was then stirred for 1 h before TEA (141 mg,
1.4 mmol, 4.1 eq.) was added along with BF3·Et2O (290 mg,
2.04 mmol, 6.0 eq.) and the mixture was refluxed at 80 °C for
45 min. The mixture was then cooled to rt, before being
filtered through a silica plug eluted with DCM. The resulting
solution was then concentrated under vacuum to aﬀord the
crude product. The crude product was purified by flash
column chromatography to aﬀord the pure product 38 as an
orange/green metallic solid (42 mg, 0.089 mmol, 26%).
Rf = 0.55 (DCM); (found (ESI)) [M + Na]
+ 479.1351
C26H19BF2N2NaO3 requires 479.1354; vmax 1545, 1410, 1385,
1261, 1114, 1078 and 956 cm−1; δH (500 MHz, CDCl3) 7.94 (2H,
brs, 2 × NCHCHCH), 7.40–7.45 (1H, m, ArH), 7.27–7.31 (2H, m,
ArH), 7.23–7.26 (1H, m, ArH), 7.20–7.22 (1H, m, ArH) 7.18–7.20
(2H, m, ArH + NCHCHCH), 7.08–7.10 (1H, m, NCHCHCH),
6.59 (2H, brs, 2 × NCHCHCH), 4.71 (1H, d, J 15.4, CHH), 4.62
(1H, d, J 15.4, CHH), 4.50 (1H, d, J 15.4, CHH), 4.41 (1H, d,
J 15.4, CHH), 3.97 (3H, s, OCH3); δC (125 MHz, CDCl3) 154.5,
153.2, 146.8, 145.1, 143.9, 137.3, 134.9, 131.7, 129.8, 126.7,
127.0, 124.4, 122.6, 118.6, 113.6, 87.2, 86.7, 63.7, 60.6, 56.1;
m/z (ESI) 479 ([M + Na]+; fluorescence (MeCN; λex = 508 nm);
λem = 519 nm; UV-Vis (MeCN) λmax (ε/M
−1 cm−1): 497
(58 563) nm.
(Me, Et, Me) BoDIPY clicked product 39 and 40
These compounds are novel. We have not confirmed which
regioisomer is which, however tentative assignments have
been made; full details are in the ESI.†
To a solution of (Me, Et, Me) BoDIPY alkyne (28.4 mg,
0.05 mmol, 1 eq.) in CDCl3 (0.5 mL), benzylazide (0.56 mg,
5.2 µL, 0.05 mmol, 1 eq.) was added. The reaction was followed
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2018 Org. Biomol. Chem.
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
2 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
1/
19
/2
01
8 
9:
49
:1
8 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
by 1H NMR. The solvent was then removed under vacuum to
give the crude product. This was then purified by flash column
chromatography (eluent EtOAc–Hexane gradiant 1 : 4–1 : 1), to
give the pure products 39 and 40 in a 1 : 1 ratio as two isolable
regioisomers A (first to elute) and B (second to elute).
Regioisomer A: (13 mg, 0.0185 mmol, 37%). Rf = 0.4
(EtOAc–Hexane 1 : 1); (found (ESI)) [M + Na]+ 724.3238.
C41H42BF2N5NaO3 requires 724.3248; νmax 2960, 2923, 2853,
1539, 1472, 1314, 1181, 973 and 751 cm−1; δH (500 MHz,
CDCl3) 7.29–7.33 (3H, m, ArH), 7.21–7.25 (1H, m, ArH), 7.16
(1H, d, J 8.4, ArH), 7.09–7.14 (2H, m, ArH), 7.04 (1H, d, J 7.0,
ArH), 6.95, (1H, t, J 7.4, ArH), 6.87 (1H, s, ArH), 6.82 (1H, s,
ArH), 5.75 (1H, d, J 15.6, NCHH), 5.49 (1H, d, J 14.3, OCHH),
5.51 (1H, d, J 12.8, OCHH), 5.43 (1H, d, J 15.6, NCHH), 5.19
(1H, d, J 14.3, OCHH), 4.77 (1H, d, J 12.8, OCHH), 3.87 (3H, s,
OCH3), 2.54 (3H, s, CH3), 2.52 (3H, s, CH3), 2.25–2.38 (4H, m,
2 × CH2CH3),1.52 (3H, s, CH3), 1.45 (3H, s, CH3) 1.03 (3H, t,
J 7.4, CH2CH3), 0.98 (3H, t, J 7.4, CH3); δC (125 MHz, CDCl3)
154.0, 152.5, 146.9, 145.2, 145.2, 139.4, 135.1, 134.3, 132.9,
132.5, 131.7, 130.6, 129.1, 129.0, 128.7, 128.4, 127.0, 122.4,
121.7, 113.4, 111.5, 63.0, 61.4, 56.2, 52.0, 23.6, 17.1, 12.5, 11.9
and 11.6; m/z (ESI) 724 ([M + Na]+); fluorescence (MeCN; λex =
528 nm); λem = 535 nm; UV-Vis (MeCN) λmax (ε/M
−1 cm−1): 521
(14 466) nm. Regioisomer B: (13 mg, 0.0185 mmol, 37%). Rf =
0.3 (EtOAc–Hexane 1 : 1); (Found (ESI)) [M + Na]+ 724.3245
C41H42BF2N5NaO3 requires 724.3241; νmax 2960, 2923, 2853,
1539, 1472, 1314, 1181, 973 and 751 cm−1; δH (500 MHz,
CDCl3) 7.42–7.46 (3H, m, ArH), 7.27–7.33 (3H, m, ArH), 7.16
(1H, d, J 8.4, ArH), 7.01–7.06 (1H, m, ArH), 6.90–6.93 (2H, m,
ArH), 6.86, (1H, d, J 2.0, ArH), 6.73 (1H, d, J 2.0, ArH), 6.82
(1H, s, ArH), 5.80 (1H, d, J 11.6, OCHH), 5.73 (1H, d, J 14.3,
NCHH), 5.53 (1H, d, J 14.3, NCHH), 5.38 (1H, d, J 14.5, OCHH),
5.02 (1H, d, J 14.5, OCHH), 4.95 (1H, d, J 11.6, OCHH), 3.91
(3H, s, OCH3), 2.49–2.55 (6H, m, 2 × CH3), 2.24–2.37 (4H, m,
2 × CH2CH3), 1.53 (3H, s, CH3), 1.39 (3H, s, CH2CH3),
0.94–1.06 (6H, m, 2 × CH3); δc (125 MHz, CDCl3) 153.9, 153.8,
147.3, 144.6, 139.7, 134.3, 133.4, 133.1, 131.4, 130.8, 129.5,
129.3, 129.0, 128.9, 128.8, 127.6, 127.0, 122.3, 122.1, 113.5,
112.1, 67.6, 58.1, 56.3, 52.9, 17.1, 12.5, 12.0, 11.6; m/z (ESI) 724
([M + Na]+); fluorescence (MeCN; λex = 528 nm); λem = 535 nm;
UV-Vis (MeCN) λmax (ε/M
−1 cm−1): 521 (14 466) nm.
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